>latest-news

Jagsonpal Pharmaceuticals Boosts Portfolio With Strategic Yash Pharma Acquisition

Jagsonpal acquires Yash Pharma, expanding into dermatology and pediatrics, enhancing market position.

Breaking News

  • Jun 28, 2024

  • Mrudula Kulkarni

Jagsonpal Pharmaceuticals Boosts Portfolio With Strategic Yash Pharma Acquisition

Jagsonpal Pharmaceuticals has announced the acquisition of Yash Pharma's businesses in India and Bhutan, facilitated by boutique investment banking firm Growthally Advisors. This strategic move not only expands Jagsonpal's therapeutic footprint but also strengthens its market position significantly.

The merger is particularly noteworthy as it brings together two companies with complementary strengths. With a 60-year legacy focused on gynaecology and orthopaedics, Jagsonpal Pharmaceuticals now integrates Yash Pharma's extensive portfolio of 33 dermatology and paediatrics brands. This expansion not only diversifies Jagsonpal's product range but also marks its entry into a new market segment valued at Rs 20,000 crore (Source: IQVIA), promising substantial growth prospects.

Investor presentation of Jagsonpal stated, “This acquisition is the perfect recipe for Jagsonpal. Yash Pharma’s strengths in dermatology and pediatrics can now be leveraged to align with our long-term growth objectives. Now, with our portfolio getting extended with this access to new customer segments, the company is poised to significantly strengthen our market position.”

Growthally Advisors Pvt. Ltd., a specialized boutique investment banking firm well-versed in the nuances of the Indian Pharmaceutical and Healthcare sectors, successfully guided this intricate transaction. Leveraging their deep expertise in mergers and acquisitions, they seamlessly aligned their vision of fostering sustainable and profitable long-term growth with Jagsonpal’s strategic objectives.

“We are proud to have been facilitators of this mutually rewarding partnership. We have always been helping emerging corporates in an Indian Pharmaceuticals and healthcare industry in unlocking their long-term objectives through innovative solutions that optimise their growth trajectory. We believe that this transaction is a perfect example of how strategic acquisitions can ensure benefits for all stakeholders”, stated Bhupinder Garg, Managing Director of Growthally Advisors.

 

Ad
Advertisement